Patents by Inventor Chiori Ijichi
Chiori Ijichi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230085282Abstract: A technique for predicting the presence or absence of an aroma property or an olfactory receptor activation property in a substance is provided. The presence or absence of the objective property is predicted for a test substance on the basis of the maximum similarity of stereochemical structure between the test substance and a reference substance.Type: ApplicationFiled: September 30, 2022Publication date: March 16, 2023Applicant: AJINOMOTO CO., INC.Inventors: Yusuke IHARA, Chiori IJICHI, Yayoi KAWATO, Yasuko SOMEKAWA, Takatsugu HIROKAWA
-
Publication number: 20230028073Abstract: An agent containing at least one aroma compound selected from the group consisting of E-beta-damascone, S-(2-methyl-3-furyl)ethanethioate, beta-caryophyllene oxide, beta-ionone, 2,5-dihydroxy-1,4-dithiane, methyl anthranilate, S-furfuryl thioformate, 1-isothiocyanate-3-(methylthio)propane, nootkatone, 1,4-dioxacycloheptadecane-5,17-dione, sclareol, and sclareolide is effective for masking an unpleasant smell and for making oral products in which an unpleasant smell is masked.Type: ApplicationFiled: September 22, 2022Publication date: January 26, 2023Applicant: AJINOMOTO CO., INC.Inventors: Yuji NAKADA, Yayoi KAWATO, Shingo SUGIYAMA, Seiji KITAJIMA, Chiori IJICHI
-
Publication number: 20210239714Abstract: Measuring the amount of lipocalin 15 in an olfactory mucosa sample or an olfactory mucus sample taken from a mammal is useful for non-subjectively and objectively diagnosing olfactory sense and is easily applied to clinical practice.Type: ApplicationFiled: April 22, 2021Publication date: August 5, 2021Applicant: Ajinomoto Co., Inc.Inventors: Chiori IJICHI, Kenji KONDO, Ayaka SHIRASAWA, Kunio NAKATA, Kazutaka SHIMBO, Yutaka MARUYAMA, Yayoi KAWATO
-
Publication number: 20130041000Abstract: Azole compounds represented by formula I: wherein ring A is isoxazole and the like, R1 is a substituted or unsubstituted aryl group and the like, R2 is a hydrogen atom and the like, and R3 is a substituted or unsubstituted alkyl group and the like, and pharmaceutically acceptable salts thereof inhibit the physiological activity of lysophosphatidic acid (LPA), and are useful as for the prophylaxis or treatment of diseases in which inhibition of the physiological activity of LPA is useful for the prophylaxis or treatment thereof, such as diseases involving the LPA receptor.Type: ApplicationFiled: August 14, 2012Publication date: February 14, 2013Applicant: AJINOMOTO CO., INC.Inventors: Takashi YAMAMOTO, Akira Chiba, Koichi Fujita, Yuka Kataba, Koji Ohsumi, Sayaka Asari, Naoyuki Fukuchi, Misato Noguchi, Itsuya Tanabe, Chiori Ijichi, Naoko Oomuta, Yuko Iida, Satoshi Iwayama
-
Publication number: 20090170911Abstract: Azole compounds represented by formula I: wherein ring A is isoxazole and the like, R1 is a substituted or unsubstituted aryl group and the like, R2 is a hydrogen atom and the like, and R3 is a substituted or unsubstituted alkyl group and the like, and pharmaceutically acceptable salts thereof inhibit the physiological activity of lysophosphatidic acid (LPA), and are useful as for the prophylaxis or treatment of diseases in which inhibition of the physiological activity of LPA is useful for the prophylaxis or treatment thereof, such as diseases involving the LPA receptor.Type: ApplicationFiled: February 20, 2009Publication date: July 2, 2009Applicant: AJINOMOTO CO. INCInventors: Takashi YAMAMOTO, Akira Chiba, Koichi Fujita, Yuka Kataba, Koji Ohsumi, Sayaka Asari, Naoyuki Fukuchi, Misato Noguchi, Itsuya Tanabe, Chiori Ijichi, Naoko Oomuta, Yuko Iida, Satoshi Iwayama
-
Patent number: 7517996Abstract: Azole compounds represented by formula I: wherein ring A is isoxazole and the like, R1 is a substituted or unsubstituted aryl group and the like, R2 is a hydrogen atom and the like, and R3 is a substituted or unsubstituted alkyl group and the like, and pharmaceutically acceptable salts thereof inhibit the physiological activity of lysophosphatidic acid (LPA), and are useful as for the prophylaxis or treatment of diseases in which inhibition of the physiological activity of LPA is useful for the prophylaxis or treatment thereof, such as diseases involving the LPA receptor.Type: GrantFiled: February 3, 2006Date of Patent: April 14, 2009Assignee: Ajinomoto Co., Inc.Inventors: Takashi Yamamoto, Akira Chiba, Koichi Fujita, Yuka Kataba, Koji Ohsumi, Sayaka Asari, Naoyuki Fukuchi, Misato Noguchi, Itsuya Tanabe, Chiori Ijichi, Naoko Oomuta, Yuko Iida, Satoshi Iwayama
-
Publication number: 20080175837Abstract: The present invention provides a Dpp4 inhibitor which comprises a leucine derivative of the following formula (1) or a methionine derivative of the following formula (2): wherein each R1 and R3 represents a hydrogen atom (H) and an L-amino acid residue; R2 represents a hydroxyl group (OH), alkoxy group having 1 to 6 carbon atoms, amino group (NH2), alkylamino group having 1 to 6 carbon atoms, glycine residue, ?-alanine residue, L-amino acid (except for proline, alanine and phenylalanine) residue or L-amino-acid amide (except for proline amide, alanine amide and phenylalanine amide) residue; and R4 represents a hydroxyl group (OH), alkoxy group having 1 to 6 carbon atoms, amino group (NH2), alkylamino group having 1 to 6 carbon atoms, glycine residue, ?-alanine residue, L-amino acid (except for proline and alanine) residue or L-amino-acid amide (except for proline amide and alanine amide) residue. These derivatives also act as autophagy regulators.Type: ApplicationFiled: October 29, 2007Publication date: July 24, 2008Applicant: AJINOMOTO CO., INCInventors: Chiori Ijichi, Naoyuki Yamada, Toshihiro Hatanaka, Kenji Takehana, Giovanni Miotto, Oriano Marin, Andrea Carpi, Denis Bertaggia
-
Patent number: 7375085Abstract: In the present specification is disclosed a melanocyte-stimulating hormone inhibitory composition which comprises, as the active ingredient, a di- or tripeptide derivative having a certain naphthyl group or the salts thereof, or a melanocyte-stimulating hormone inhibitory compound having a 50% inhibitory concentration of cAMP production (IC50) of 100 nM or less, which composition can prevent pigmentation, or can prevent, improve or recover from immune abnormality or immunodeficiency, or regulate body weight by appetite control, and also can be used as cosmetics or external preparations for the skin, and in addition, can be produced easily, and are excellent in the stability during storage.Type: GrantFiled: April 25, 2000Date of Patent: May 20, 2008Assignee: Ajinomoto Co., Inc.Inventors: Eiji Shiojiri, Yoshinobu Takino, Hiromi Chujou, Kazutami Sakamoto, Chiori Ijichi, Yuzuru Eto, Keiji Iwasaki
-
Publication number: 20060194850Abstract: Azole compounds represented by formula I: wherein ring A is isoxazole and the like, R1 is a substituted or unsubstituted aryl group and the like, R2 is a hydrogen atom and the like, and R3 is a substituted or unsubstituted alkyl group and the like, and pharmaceutically acceptable salts thereof inhibit the physiological activity of lysophosphatidic acid (LPA), and are useful as for the prophylaxis or treatment of diseases in which inhibition of the physiological activity of LPA is useful for the prophylaxis or treatment thereof, such as diseases involving the LPA receptor.Type: ApplicationFiled: February 3, 2006Publication date: August 31, 2006Applicant: AJINOMOTO CO. INCInventors: Takashi Yamamoto, Akira Chiba, Kouichi Fujita, Yuka Kataba, Koji Ohsumi, Sayaka Asari, Naoyuki Fukuchi, Misato Noguchi, Itsuya Tanabe, Chiori Ijichi, Naoko Oohmuta, Yuko Iida, Satoshi Iwayama